Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

December 20
18:20 2022

New York, USA – December 20, 2022 – As one of the leading chemical manufacturers and suppliers globally, Alfa Chemistry is well-prepared to provide a number of active pharmaceutical ingredients (APIs), such as donepezil and dexmedetomidine hydrochloride, for customers worldwide ranging from lab to commercial scale. Earlier this month, the company announced that three other APIs had been introduced for its global customers as well, namely, lenalidomide, parecoxib sodium, and rivaroxaban.

“With highly skilled Ph.D. and M.S. synthetic chemists as well as advanced technological facilities, we are able to meet the highest manufacturing standards to synthesize innovative small molecular APIs for pharmaceutical companies across the world,” said the Marketing Chief of Alfa Chemistry. “Throughout the manufacturing process, we focus extensively on the safety of API production on the one hand and pay attention to ensure all quality standards and cGMP requirements are met on the other.”


The lenalidomide API provided by Alfa Chemistry can be used in research applications or medication production for the treatment of cancerous and anemia patients who are suffering from certain blood/bone marrow disorders. Lenalidomide, as an oral immunomodulatory drug, revealed a good safety profile.

Parecoxib Sodium

Alfa Chemistry offers high-quality parecoxib sodium as API to support the amide prodrug of the cyclooxygenase II (COX-2)-selective inhibitor, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, which has anti-inflammatory, analgesic, and antipyretic activities.


Rivaroxaban, as an antithrombotic drug, is widely used in the treatment and prevention of deep vein thrombosis (DVT) symptoms prior to hip or knee replacement surgery, treatment of venous thromboembolism (VTE) and nonvalvular atrial fibrillation, as well as treatment of DVT and pulmonary embolism (PE). Alfa Chemistry offers rivaroxaban for related research and manufacturing.

All APIs provided by Alfa Chemistry meets the CP & EP standards. Please visit to learn more.

About Alfa Chemistry

Aiming to provide attractive solutions for drug developers, Alfa Chemistry offers not only a variety of synthetic chemical APIs which can be used in pharmaceutical preparation but also a comprehensive line of supportive services covering areas like pre-formulation for drug discovery, formulation, process development, custom synthesis, and scale up.

Media Contact
Company Name: Alfa Chemistry
Contact Person: Tylor Keller
Email: Send Email
Phone: 1-516-734-6573
Country: United States